Medication-related osteonecrosis of the posterior maxilla: surgical treatment using a combined transnasal endoscopic and intraoral approach, our experience with seven consecutive patients

Clin Otolaryngol. 2018 Apr;43(2):685-691. doi: 10.1111/coa.12999. Epub 2017 Oct 24.

Authors

P Procacci¹, M Albanese¹, L Trevisiol¹, V Favero¹, D Bertossi¹, F Lonardi¹, A D'Agostino¹, E Manfrin², P F Nocini¹

Affiliations

¹ Section of Oral and Maxillofacial Surgery, Department of Surgery, University of Verona, Verona, Italy.
² Department of Diagnostics and Public Health, Section of Pathology, University of Verona, Verona, Italy.

PMID: 28981207
DOI: 10.1111/coa.12999

No abstract available

MeSH terms

Aged
Bisphosphonate-Associated Osteonecrosis of the Jaw / diagnosis
Bisphosphonate-Associated Osteonecrosis of the Jaw / etiology
Bisphosphonate-Associated Osteonecrosis of the Jaw / surgery*
Bone Density Conservation Agents / adverse effects*
Denosumab / adverse effects*
Female
Humans
Male
Maxilla*
Middle Aged
Natural Orifice Endoscopic Surgery*
Retrospective Studies
Treatment Outcome

Substances

Bone Density Conservation Agents
Denosumab